Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: A cost-effectiveness evaluation based on data collected over 8 years of service provision

Osteoporosis International

Volumn 22, Issue 7, 2011, Pages 2083-2098

  McLellan, A R ^a   Wolowacz, S E ^b   Zimovetz, E A ^b   Beard, S M ^b   Lock, S ^b   McCrink, L ^b   Adekunle, F ^c   Roberts, D ^c  

^a WESTERN INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Novartis Pharmaceuticals UK Ltd   (United Kingdom)

Author keywords

Economics; Fracture; Fracture liaison service; Heath services; Osteoporosis; Secondary prevention

Indexed keywords

ALENDRONIC ACID; CALCIUM; ETIDRONIC ACID; IBANDRONIC ACID; RALOXIFENE; RISEDRONIC ACID; VITAMIN D;

AGED; ARTICLE; BUDGET; COST EFFECTIVENESS ANALYSIS; FEMALE; FRAGILITY FRACTURE; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; COST-BENEFIT ANALYSIS; DIETARY SUPPLEMENTS; DIPHOSPHONATES; FEMALE; GREAT BRITAIN; HIP FRACTURES; HUMANS; HUMERAL FRACTURES; MALE; MIDDLE AGED; MODELS, ECONOMIC; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; QUALITY OF LIFE; RISK FACTORS; SECONDARY PREVENTION; WRIST INJURIES;

EID: 79959918480     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-011-1534-0     Document Type: Article

References (32)

1. AR McLellan SJ Gallacher M Fraser C McQuillian 2003 The FLS: success of a program for the evaluation and management of patients with osteoporotic fracture Osteoporos Int 14 1028 1034 14600804 10.1007/s00198-003-1507-z (Pubitemid 40824270)
2. National Institute for Health and Clinical Excellence. (2008a) Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women. Guidance and Assessment Report No. 160. http://www.nice.org.uk/nicemedia/pdf/ Assessment-report-osteo.pdf. Accessed 14 September 2009
3. National Institute for Health and Clinical Excellence. (2008b) Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. Guidance and Assessment Report No. 161. http://www.nice.org.uk/nicemedia/pdf/Osteo%20-AR.pdf. Accessed 14 September 2009
4. Royal College of Physicians. (1999) Osteoporosis: clinical guidelines for prevention and treatment. http://www.rcplondon.ac.uk/Pubs/brochure.aspx?e=136. Accessed 24 September 2009
5. Scottish Intercollegiate Guidelines Network. (2003) Guideline 71: management of osteoporosis. http://www.sign.ac.uk/pdf/sign71.pdf. Accessed 24 September 2009
6. McLellan AR, Reid DM, Forbes K, Reid R, Campbell C, Gregori A, Raby N, Simpson A (2004) Effectiveness of strategies for the secondary prevention of osteoporotic fractures in Scotland, an audit funded by NHS Quality Improvement Scotland (Project CEPS 99/03). http://www.nhshealthquality.org/nhsqis/2755.html. Accessed 2 November 2009
7. Hippisley-Cox J, Bayly J, Potter J, et al. (2007) Evaluation of standards of care for osteoporosis and falls in primary care. QRESEARCH and NHS: the Information Centre for health and social care. http://www.ic.nhs.uk/webfiles/ publications/GPosteoporisiscare/ Evaluation%20of%20Standards%20of%20Care%20for%20Osteoporosis%20and%20Falls%20in %20Primary%20Care%20Report.pdf. Accessed 24 September 2009
8. Royal College of Physicians, The Clinical Effectiveness and Evaluation Unit, Clinical Standards Department. (2009) National audit of the organisation of services for falls and bone health of older people. http://www.rcplondon.ac. uk/clinical-standards/ceeu/Current-work/Falls/Documents/National-Falls-and-Bone- Health-Public-Audit-Report-March-2009.pdf. Accessed 14 September 2009
9. M Fraser AR McLellan 2004 A fracture liaison service for patients with osteoporotic fractures Prof Nurse 19 5 286 290 14737805
10. Department of Health (2009c). Falls and fractures, effective interventions in health and social care. http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-103146. Accessed 16 December 2009
11. Royal College of Physicians, The Clinical Effectiveness and Evaluation Unit of the Royal College of Physicians. (2007) National clinical audit of falls and bone health in older people. http://www.rcplondon.ac.uk/clinical-standards/ ceeu/Documents/fbhop-nationalreport.pdf. Accessed 14 September 2009
12. SR Majumdar JA Johnson DA Lier, et al. 2007 Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial Osteoporos Int 18 3 261 270 17086470 10.1007/s00198-006-0248-1 1:STN:280:DC%2BD2s%2FoslOltQ%3D%3D (Pubitemid 46233171)
13. SR Majumdar DA Lier LA Beaupre, et al. 2009 Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial Arch Intern Med 169 1 25 31 19139320 10.1001/archinte.169.1.25
14. B Sander V Elliot-Gibson D Beaton ER Bogoch A Maetzel 2008 A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs J Bone Joint Surg 90 1197 1205 18519311 10.2106/JBJS.G.00980 (Pubitemid 351778125)
15. R Dell D Greene SR Schelkun K Williams 2008 Osteoporosis disease management: the role of the orthopaedic surgeon J Bone Joint Surg 90 Suppl. 4 188 194 18984730 10.2106/JBJS.H.00628
16. Department of Health. (2009a) DH/SC,LG & CP Directorate/Older People and Dementia Fracture Prevention Services: an economic evaluation. 25 November 2009. http://www.dh.gov.uk/prod-consum-dh/groups/dh-digitalassets/documents/ digitalasset/dh-110099.pdf Accessed 22 February 2010
17. IMS BPI/HPAI. July 2009.
18. National Institute for Health and Clinical Excellence. (2008c) Guide to the methods of technology appraisal. http://www.nice.org.uk/media/B52/A7/ TAMethodsGuideUpdatedJune2008.pdf. Accessed 14 September 2009
19. National Collaborating Centre for Nursing & Supportive Care. (2008) Osteoporosis: evidence review. Systematic reviews of clinical effectiveness prepared for the guideline "Osteoporosis: assessment of fracture risk and the prevention of osteoporotic fractures in individuals at high risk". http://www.nice.org.uk/guidance/index.jsp?action=folder&o=42361. Accessed 24 November 2009
20. HC Bucher GH Guyatt LE Griffith SD Walter 1997 The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials J Clin Epidemiol 50 683 691 9250266 10.1016/S0895-4356(97)00049-8 1:STN:280:DyaK2szptlygsw%3D%3D (Pubitemid 27341818)
21. CM Robinson M Royds A Abraham MM McQueen CM Court-Brown J Christie 2002 Refractures in patients at least forty-five years old. a prospective analysis of twenty-two thousand and sixty patients J Bone Joint Surg Am 84-A 9 1528 1533 12208908 1:STN:280:DC%2BD38vltlyiuw%3D%3D (Pubitemid 35014701)
22. Bailey K, Ellis C, Majeed A. (2002) Trends in the treatment of osteoporosis and types of drug treatments prescribed in general practice in England and Wales, 1994 to 1998. Health Statistics Quarterly. http://www.statistics.gov.uk/downloads/theme-health/HSQ16.pdf. Accessed 14 September 2009
23. Kanis JA, Brazier J, Stevenson M, et al. (2002) Treatment of established osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess 6(29)
24. Office for National Statistics (2008) Mortality rates 2001, deaths 2001: rates per 1000 population by age-group and sex in the UK. Taken from Table 6 published in Mortality Statistics, General, 2001 (series DH1 No. 34). http://www.statistics.gov.uk/statbase. Accessed 14 September 2009
25. M Stevenson JM Lloyd NE De 2005 A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. Systematic review Health Technol Assess 9 1 160 15929857 1:STN:280:DC%2BD2M3osFCrtQ%3D%3D
26. T Peasgood K Herrmann JA Kanis JE Brazier 2009 An updated systematic review of health state utility values for osteoporosis related conditions Osteoporos Int 20 6 853 868 19271098 10.1007/s00198-009-0844-y 1:STN:280:DC%2BD1MzjtVKksg%3D%3D
27. National Institute for Health and Clinical Excellence. (2008d) Osteoporosis-primary prevention: costing template. http://guidance.nice.org.uk/ TA160/CostTemplate/xls/English. Accessed 13 November 2009
28. NHS Cancer Screening Programmes. (2010) About cervical screening. http://www.cancerscreening.nhs.uk/cervical/about-cervical-screening.html#cost. Accessed 15 November 2010
29. Curtis L. (2009) Unit costs of health and social care 2008. Personal Social Services Research Unit, the University of Kent. http://www.pssru.ac.uk/ pdf/uc/uc2008/uc2008.pdf. Accessed 10 March 2009
30. Department of Health. (2009b) National Reference Costs 2007-08. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-098945. Accessed 12 August 2009
31. Monthly Index of Medical Specialities, Haymarket Medical Media, London (2010) http://www.mims.co.uk/home/. Accessed 20 January 2010
32. MD Stevenson SE Davis JA Kanis 2006 The hospitalisation costs and out-patient costs of fragility fractures Womens Health Med 3 4 149 151 10.1383/wohm.2006.3.4.149